메뉴 건너뛰기




Volumn 40, Issue 6, 2002, Pages 1240-1243

Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation

Author keywords

Allosensitization; Cadaver vein allograft; Hemodialysis (HD) access

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

EID: 0036894018     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.36892     Document Type: Article
Times cited : (29)

References (9)
  • 3
    • 0029090047 scopus 로고
    • Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgery
    • Iaffaldano RA, Lewis BE, Johnson SA, Piffare R, McKiernan TL: Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgery. Chest 108:725-729, 1995
    • (1995) Chest , vol.108 , pp. 725-729
    • Iaffaldano, R.A.1    Lewis, B.E.2    Johnson, S.A.3    Piffare, R.4    McKiernan, T.L.5
  • 5
    • 0035408322 scopus 로고    scopus 로고
    • Use of cyropreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization
    • Benedetto B, Lipkowitz GL, Madden RL, et al: Use of cyropreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. J Vasc Surg 34:139-142, 2001
    • (2001) J Vasc Surg , vol.34 , pp. 139-142
    • Benedetto, B.1    Lipkowitz, G.L.2    Madden, R.L.3
  • 6
    • 0035022429 scopus 로고    scopus 로고
    • Transformation of nonvascular acellular tissue matrices into durable vascular conduits
    • Clarke DR, Lust RM, Sun YS, Black KS, Ollerenshaw JD: Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg 71:S433-S436, 2001 (suppl 5)
    • (2001) Ann Thorac Surg , vol.71 , Issue.SUPPL. 5
    • Clarke, D.R.1    Lust, R.M.2    Sun, Y.S.3    Black, K.S.4    Ollerenshaw, J.D.5
  • 8
    • 0033202201 scopus 로고    scopus 로고
    • The SynerGraft valve: A new acellular (nonglutaraldehyde fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation
    • Obrien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D: The SynerGraft valve: A new acellular (nonglutaraldehyde fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11:194-200, 1999
    • (1999) Semin Thorac Cardiovasc Surg , vol.11 , pp. 194-200
    • Obrien, M.F.1    Goldstein, S.2    Walsh, S.3    Black, K.S.4    Elkins, R.5    Clarke, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.